Absci (NASDAQ:ABSI – Get Free Report) is expected to be posting its quarterly earnings results after the market closes on Tuesday, March 18th. Analysts expect Absci to post earnings of ($0.23) per share and revenue of $1.77 million for the quarter. Individual interested in participating in the company’s earnings conference call can do so using this link.
Absci Stock Up 8.3 %
ABSI stock opened at $3.14 on Monday. The company has a market cap of $360.65 million, a P/E ratio of -3.38 and a beta of 2.09. Absci has a 52 week low of $2.45 and a 52 week high of $6.72. The company’s 50-day moving average price is $3.87 and its 200 day moving average price is $3.70. The company has a current ratio of 5.63, a quick ratio of 5.63 and a debt-to-equity ratio of 0.01.
Wall Street Analysts Forecast Growth
A number of analysts recently commented on the stock. KeyCorp decreased their price objective on shares of Absci from $6.00 to $5.00 and set an “overweight” rating on the stock in a report on Wednesday, January 8th. HC Wainwright reaffirmed a “buy” rating and issued a $7.00 price target on shares of Absci in a report on Friday, January 17th. Guggenheim reaffirmed a “buy” rating and issued a $10.00 price target on shares of Absci in a report on Tuesday, December 3rd. Finally, Needham & Company LLC began coverage on shares of Absci in a report on Wednesday, January 22nd. They issued a “buy” rating and a $9.00 price target on the stock. Seven research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the company has an average rating of “Buy” and a consensus target price of $8.57.
About Absci
Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to create biologics for patients. Its integrated drug creation platform is designed to improve upon traditional biologic drug discovery by using AI to simultaneously optimize multiple drug characteristics that may be important to development and therapeutic benefit.
Featured Stories
- Five stocks we like better than Absci
- What Are Trending Stocks? Trending Stocks Explained
- How to Build the Ultimate Everything ETF Portfolio
- What is the Hang Seng index?
- Dutch Bros or Starbucks: Which Coffee Stock Has More Growth?
- There Are Different Types of Stock To Invest In
- 3 Stocks With High ROE and Market-Beating Growth Potential
Receive News & Ratings for Absci Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Absci and related companies with MarketBeat.com's FREE daily email newsletter.
